Changes in beta 2-glycoprotein I antigenicity induced by phospholipid binding

beta 2-glycoprotein I (beta 2GPI) or apolipoprotein H has been described as a necessary cofactor for antiphospholipid antibody (aPA) binding in ELISA. Some investigators disagree with the beta 2-GPI requirement whereas data from other laboratories indicate that beta 2GPI, not phospholipid (PL), is the antigen for aPA. To investigate the cofactor we have produced three IgG1 monoclonal antibodies (mAb) to human beta 2GPI; 3G9, 1B4 and 3D11. Western blot analyses showed the mAb to bind human beta 2GPI (40 kDa), but no reactivity was observed with adult or fetal bovine sera. In contrast, rabbit anti-beta 2GPI reacted with both human and bovine sera. None of the mAb reacted with phosphatidylserine (PS) or cardiolipin (CL) by ELISA. There were no significant differences in ELISA binding to purified beta 2GPI when the mAb were adjusted to the same concentration. mAb 3G9 and 1B4 gave stronger signals in ELISA after beta 2GPI bound to PS; the increase for 3G9 was significantly greater than for 1B4 (p < 0.002). mAb 3D11 was unique inasmuch as it failed to recognize beta 2PGI bound to PS. In comparison, the rabbit anti-beta 2GPI was unaffected by PS-beta 2GPI binding. These observations indicate that the mAb recognize three distinct epitopes on beta 2GPI. The data suggest that beta 2GPI undergoes conformational changes subsequent to binding PL. Our findings are consistent with the hypothesis that aPA recognize a beta 2GPI neotope formed subsequent to binding PL.